Walid Gharib, MD
Cardiovascular Disease · Morgantown, WVNPI 1063655264
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,806 of the $6,060 with a category attached, or 79.3%. It is spread thinly across 25 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,001 and has fallen 82.7% since, to $346 in 2025.
Across 266 payments — averaging $22.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Terumo Medical Corporation$1K
- Pfizer$661
- AstraZeneca$585
- Johnson & Johnson$518
- Amgen$344
- Novartis$281
- plus $2K from 19 others
What the payments were for
- Travel & lodging$1,04017%
- Food & beverage$4,80679%
- Education$2144%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Terumo Medical Corporation | 12 | $1,270 |
| Pfizer | 41 | $661 |
| AstraZeneca | 34 | $585 |
| Johnson & Johnson | 36 | $518 |
| Amgen | 20 | $344 |
| Novartis | 18 | $281 |
| Actelion Pharmaceuticals US, Inc. | 8 | $273 |
| Boehringer Ingelheim | 17 | $247 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 23 | $234 |
| Stryker | 2 | $200 |
| Boston Scientific | 4 | $189 |
| Edwards Lifesciences | 3 | $169 |
| Merck | 11 | $168 |
| E.r. Squibb & Sons, L.L.C. | 11 | $167 |
| Inari Medical, Inc. | 1 | $142 |
| Regeneron Healthcare Solutions, Inc. | 7 | $123 |
| Bristol Myers Squibb | 1 | $121 |
| Sanofi-aventis U.S. LLC | 7 | $105 |
| Heartflow, Inc. | 1 | $86 |
| Amarin Pharma, Inc. | 4 | $53 |
| Portola Pharmaceuticals, LLC | 1 | $41 |
| Abiomed | 1 | $35 |
| Astellas Pharma US Inc | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| ZOLL Circulation Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,060 in reported general payments places this provider in the 70th percentile of 100 cardiovascular disease providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 44 | $227 |
| ClopidogrelClopidogrel Bisulfate | 27 | $211 |
| Rosuvastatin Calcium | 25 | $122 |
| Atorvastatin Calcium | 12 | $76 |
| Amlodipine Besylate | 11 | $28 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Morgantown
- Partho SenguptaMorgantown$131K
- Madhavi KadiyalaMorgantown$29K
- David CampseyMorgantown$21K
- Morgan LyonsMorgantown$7K
- Muchi Ditah ChobufoMorgantown$7K
- Raahat BansalMorgantown$6K
- David TinglerMorgantown$6K
- Yasmin HamiraniMorgantown$5K
- Ruby HavistinMorgantown$4K
- Mohamed Al HajjiMorgantown$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.